By BARRY MEIER
ABINGDON, Va., May 10 —The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential to be abused.
To resolve criminal and civil charges related to the drug’s “misbranding”, the parent of Purdue Pharma, the company that markets OxyContin, agreed to pay more than $600 million in fines. That is the third-highest amount ever paid by a drug company in such a case.
Also, in a rare move, three executives of Purdue Pharma, including its president and it top lawyer, pleaded guilty today as individuals to misbranding charges, a criminal violation. They agreed to pay a total of $34.5 million in fines.
And in case you missed this piece:
The Blotter
OxyContin: The Giuliani Connection
By Brian Ross, Richard Esposito and R. Schwartz
ABC News
Wednesday 09 May 2007
Rudolph Giuliani and his consulting company, Giuliani Partners, have served as key advisors for the last five years to the pharmaceutical company that pled guilty today to charges it misled doctors and patients about the addiction risks of the powerful narcotic painkiller OxyContin.
No comments:
Post a Comment